By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Zydus Pharmaceuticals (USA) Inc. 

210 Carnegie Center
Suite 103
Princeton  New Jersey  08540  U.S.A.
Phone: 609-275-5125 Fax: 609-275-0499



Company News
Supernus (SUPN) Announces Settlement With Zydus Pharmaceuticals (USA) Inc. On Trokendi XR Patent Litigation 3/7/2017 10:58:32 AM
Supernus Pharmaceuticals (SUPN) Files Lawsuit Against Zydus Pharmaceuticals (USA) Inc. In U.S. Court For Infringement Of Patents Covering Its Antiepileptic Drug, Trokendi XR 11/25/2014 7:18:12 AM
Supernus Pharmaceuticals (SUPN) Sues Zydus Pharmaceuticals (USA) Inc. For Infringement Of Trokendi XR(R) Patents 11/24/2014 12:53:42 PM
Zydus Pharmaceuticals (USA) Inc. to Recall Single Lot of Warfarin After Complaints 6/13/2013 6:36:10 AM
Somaxon Pharmaceuticals, Inc. (SOMX) Announces Settlement of Silenor Patent Litigation With Zydus Pharmaceuticals (USA) Inc. 7/19/2012 9:15:46 AM
Zydus Pharmaceuticals (USA) Inc. Selects Revitas™ Flex™ Platform to Support Growth Model 5/3/2012 10:26:47 AM
K-V Pharmaceutical Company (KV-A) to Divest Generics Business to Zydus Pharmaceuticals (USA) Inc. for $60 Million 6/17/2011 7:34:26 AM
Shire plc Files Suit against Cadila Healthcare Limited, Doing Business As Zydus Cadila and Zydus Pharmaceuticals (USA) Inc. 7/16/2010 2:29:50 PM
Cosmo Pharmaceuticals S.p.A. Reports Shire Pharmaceuticals (SHPGY) Receives LIALDA(R) Paragraph IV Notice Letter from Zydus Pharmaceuticals (USA) Inc. 6/1/2010 12:34:22 PM
Zydus Pharmaceuticals (USA) Inc. Announces FDA Final Approval for the Generic Version of Topamax(R) Tablets 3/29/2009 10:19:47 PM